GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast A/S (LTS:0QBO) » Definitions » Institutional Ownership

Coloplast A/S (LTS:0QBO) Institutional Ownership : 26.05% (As of May. 21, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Coloplast A/S Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Coloplast A/S's institutional ownership is 26.05%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Coloplast A/S's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Coloplast A/S's Float Percentage Of Total Shares Outstanding is 0.00%.


Coloplast A/S Institutional Ownership Historical Data

The historical data trend for Coloplast A/S's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast A/S Institutional Ownership Chart

Coloplast A/S Historical Data

The historical data trend for Coloplast A/S can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30
Institutional Ownership 23.70 24.32 23.66 23.92 24.22 24.87 24.94 25.27 25.82 26.05

Coloplast A/S Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Coloplast A/S (LTS:0QBO) Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast A/S (LTS:0QBO) Headlines

No Headlines